WT mice were treated daily with either vehicle or 4μ8c, an IRE1 RNase inhibitor that reduces the IL-1β signaling pathway in atherosclerosis (27), beginning 2 days prior to LCWE injection. The gene discussed is IL1B; the disease is atherosclerosis.